公开(公告)号：KR100405161B1

公开(公告)日：2003-11-12

申请号：KR1020000076298

申请日：2000-12-14

Applicant: 신풍제약주식회사

Inventor： 이성태 ,  한신 ,  박우일 ,  주정철 ,  이철규 ,  김혜선

IPC: A61K9/08

CPC classification number: A61K9/0019 ,  A61K31/192 ,  A61K47/02

Abstract: Disclosed is a formulation for intramuscular injection containingloxoprofen or a pharmaceutically acceptable salt thereof, having an excellent anti-inflammatory analgesic effect, as an active ingredient.

Abstract translation: 本发明公开了含有洛索洛芬或其药学上可接受的盐作为有效成分，具有优异的消炎镇痛作用的肌内注射用制剂。

公开(公告)号：KR100360828B1

公开(公告)日：2002-11-13

申请号：KR1019990065917

申请日：1999-12-30

Applicant: 신풍제약주식회사

Inventor： 홍성태 ,  이승진 ,  고원규 ,  주정철

IPC: A61K31/495

CPC classification number: A61K9/1652 ,  A61K9/2013 ,  A61K9/2054 ,  A61K31/4985

Abstract: 본발명은프라지콴텔을유효성분으로포함하고, 고분자물질및 결합제를적절히선택하여배합함으로써프라지콴텔의방출속도를조절한서방성구충제조성물에관한것이다.

公开(公告)号：KR1020020046407A

公开(公告)日：2002-06-21

申请号：KR1020000076298

申请日：2000-12-14

Applicant: 신풍제약주식회사

Inventor： 이성태 ,  한신 ,  박우일 ,  주정철 ,  이철규 ,  김혜선

IPC: A61K9/08

CPC classification number: A61K9/0019 ,  A61K31/192 ,  A61K47/02

Abstract: PURPOSE: Provided is a pharmaceutical composition for intramuscular injection containing loxoprofen having excellent anti-inflammatory effects, as an active ingredient, and its pharmaceutically acceptable salts. CONSTITUTION: The pharmaceutical composition for intramuscular injection contains loxoprofen represented by the formula(1) or its pharmaceutically acceptable salts. It is manufactured by dissolving loxoprofen or its pharmaceutically acceptable salt, a stabilizing agent or solution adjuvant in water for injection then sterilizing it.

Abstract translation: 目的：提供含有作为活性成分的优良抗炎作用的洛索丙芬及其药学上可接受的盐的肌内注射用药物组合物。 构成：用于肌内注射的药物组合物含有由式（1）表示的洛索洛芬或其药学上可接受的盐。 它是通过将洛索洛芬或其药学上可接受的盐，稳定剂或溶液佐剂溶解在水中，然后对其进行消毒而制造的。

公开(公告)号：KR1020010057545A

公开(公告)日：2001-07-04

申请号：KR1019990065917

申请日：1999-12-30

Applicant: 신풍제약주식회사

Inventor： 홍성태 ,  이승진 ,  고원규 ,  주정철

IPC: A61K31/495

CPC classification number: A61K9/1652 ,  A61K9/2013 ,  A61K9/2054 ,  A61K31/4985

Abstract: PURPOSE: Anthelmintic compositions capable of controlling the release velocity of praziquantel for effectively exterminating fluke, tapeworm or the like are provided, which show a worms exterminating effect equal to that of conventional formulations by taking medicine only three times a day. CONSTITUTION: The anthelmintic compositions contain praziquantel; polymer material selected from the group consisting of hydroxypropylmethylcellulose, hydroxypropylcellulose, hydroxyethylcellulose, methylcellulose and ethylcellulose; a filler selected from the group consisting of alkyl alcohol, fatty acid or salts thereof; and a binder, wherein the compositions contain 2 to 60% by weight of the polymer material based on the total weight of the compositions.

Abstract translation: 目的：提供能够控制吡喹酮释放速度以有效灭灭恙虫，绦虫等的驱虫剂，其通过每天服用药物显示与常规制剂相同的蠕虫灭活效果。 构成：驱虫组合物含有吡喹酮; 选自羟丙基甲基纤维素，羟丙基纤维素，羟乙基纤维素，甲基纤维素和乙基纤维素的聚合物材料; 选自烷基醇，脂肪酸或其盐的填料; 和粘合剂，其中所述组合物基于组合物的总重量含有2至60重量％的聚合物材料。